For this purpose, serum-virus-influenza-specific IgG antibody titre and putative GC B cell- and GC CD4+ T cell response-related correlates/surrogates of protection were evaluated following the primary QIV immunization, and the second QIV challenge (mimicking in some way subsequent natural virus influenza infection). This evidence concerns the gene CD4 and influenza.